Navigation Links
Cellectis and the Center for iPS Cells Research and Application Enter Collaboration
Date:10/25/2010

hat relate to the Company's objectives. Such forward-looking statements are based on the current expectations and assumptions of the Company's management only and involve risk and uncertainties. Potential risks and uncertainties include, without limitation, whether the Company will be successful in implementing its strategies, whether there will be continued growth in the relevant market and demand for the Company's products, new products or technological developments introduced by competitors, and risks associated with managing growth. Unfavorable developments in connection with these and other risks and uncertainties described, in particular, in the Company's prospectus prepared in connection with its IPO and on which the French Autorite des marches financiers ("AMF") granted its visa no. 07-023 on January 22, 2007, could cause the Company to fail to achieve the objectives expressed by the forward-looking statements above.


'/>"/>
SOURCE Cellectis
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cellectis Plant Sciences Licenses Plant Transformation Technology From Midwest Oilseeds
2. Cellectis Bioresearch Announces Availability of Research Kits Through New Online E-Store
3. Cellectis Unveils Its New Corporate Website
4. Taconics Litigation Contesting License Termination By Cellectis Is Dismissed
5. Cellectis bioresearch Establishes The Genome Customization Award (TGCA)
6. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
7. Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting
8. Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology
9. HumanTouch Expands Services to the Centers for Disease Control and Prevention as a Prime Contract Holder as Part of $1.0 Billion Contract
10. NSF renews Centers for Nanotechnology in Society
11. SDForum and Innovation Center Denmark Present: The Future of Health Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... Dental decay is the number one chronic disease ... Crisafulli of Crisafulli Dental those statistics are no longer daunting. ... and implemented a cavity prevention program developed by CariFree that ... to 74% . The system is known as ... a solution to dental decay that works,” says Dr. Crisafulli, ...
(Date:6/19/2013)... , June 20, 2013 ... productivity with technology solutions for pharmaceutical and chemical ... Glaxo Wellcome Manufacturing Pte. Ltd. and Siemens Pte. ... a new A*STAR R&D Consortium Programme - Innovative ... A*STAR,s Institute of Chemical and Engineering Sciences (ICES), ...
(Date:6/19/2013)... 19, 2013 An article posted earlier this ... increasing number of uses for probiotics. The article stated that ... the associate benefits may beeb listed, the actual use ... helping clear skin conditions. While the total uses of probiotics ... the the uses of these “miracle” bacterium, and debunked the ...
(Date:6/19/2013)... Clinverse, Inc. , a ... trials, today announced it will be exhibiting and ... in Boston, June 24-26, 2013. Clinverse’s eClinical ... fully configurable, cloud-based clinical financial lifecycle system. , ... Clinverse’s eClinical Commerce Network, automates site contract set-up ...
Breaking Biology Technology:Crisafulli Dental Launches Ground Breaking Cavity Prevention Program That Can Lower Decay Rates by 74% 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 3Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 4Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2
... Stem cell-enriched autologous fat enables sustainable breast augmentation ... the media: For years a French company has been ... cause cancer. More than 100,000 women worldwide must now ... or carrying a "time bomb" in their bodies. Stem ...
... Biotherapeutics (OTC.BB: NWBO) (NW Bio) today announced that it will ... the Windsor Room of the Sir Francis Drake Hotel as ... emerging biotech companies held over 3 days this week in ... attendees are expected to be listening to presentations by up ...
... SEATTLE, Jan. 10, 2012  Omeros Corporation (NASDAQ: OMER ... selectively with each of GPR25, GPR32, GPR80, GPR135 and MAS1, ... unlocked by Omeros to 23, representing 30 percent of the ... unlocked by Omeros for drug development equals half of the ...
Cached Biology Technology:Silicone Scandal: Stem Cell Breast Augmentation a Safe Alternative 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 2Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 4Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 5
(Date:6/19/2013)... Tanzania is playing a vital role in the survival ... response to climate and environmental changes, according to new ... on savannah birds from the Tanzanian Bird Atlas project ... decades - the researchers found that they are using ... areas further west where dry seasons are getting longer, ...
(Date:6/19/2013)... study of the patients who received injections of ... the New England Compounding Center has found that ... did not experience a worsening of their symptoms ... detect infection, especially among those individuals who received ... study, along with an editorial by UC Davis ...
(Date:6/19/2013)... Montreal, June 19, 2013 A study published in ... is the first report of an oral probiotic supplement ... , The lead author on the study, ... Poster Presentation Prize from the New York Academy of ... last week,s Probiotics, Prebiotics, and the Host Microbiome: ...
Breaking Biology News(10 mins):Protected areas provide African birds with stepping stones to survival 2Evolution of an outbreak: Complications from contaminated steroid injections 2Study shows probiotic Lactobacillus reuteri NCIMB 30242 significantly increased vitamin D levels 2
... Calling the results "extremely surprising," researchers from the ... report that methane gas concentrations in the Gulf of ... after a massive release occurred following the Deepwater Horizon ... led by oceanographers John Kessler of Texas A&M and ...
... exploring the genetic culprits behind a host of neuromuscular ... a team working at the National Institute of Standards ... single cells to extract and examine their mitochondria. ... "engines"the mitochondria that are in large part responsible for ...
... Jan. 6, 2011 News media now can apply for ... National Meeting & Exposition March 27-31, 2011, in Anaheim, Calif., ... Held during the International Year of Chemistry (IYC), ... Center and at area hotels. With nearly 9,500 presentations ...
Cached Biology News:UCSB, Texas A&M scientists find methane gas concentrations have returned to near-normal levels 2Extracting cellular 'engines' may aid in understanding mitochondrial diseases 2
... Band Purification Kit, 100. For the purification, isolation ... (0.1-10 kb) from solution and from TAE or ... solution in as little as 5 min or ... glass fiber matrix columns provide consistent results and ...
These disposable button tethers are designed for rat infusion studies lasting more than 2 weeks. After one to two weeks the subcutaneous tissue will grow into the Dacron mesh, making the sutures irre...
Newborn Bovine Serum Heat-Inactivated...
Mycoplasma and virus tested...
Biology Products: